Clinical Characteristics of Acromegalic Patients whose Pituitary Tumors Contain Mutant Gs Protein

CA LANDIS, G HARSH, J LYONS… - The Journal of …, 1990 - academic.oup.com
CA LANDIS, G HARSH, J LYONS, RL DAVIS, F McCORMICK, HR BOURNE
The Journal of Clinical Endocrinology & Metabolism, 1990academic.oup.com
Activating mutations in the gene for the α-chain of G8, the stimulatory regulator of adenylyl
cyclase, have been identified in human GH-secreting pituitary tumors. Using the polymerase
chain reaction and allele-specific oligonucleotide hybridization, we screened 25 GH-
secreting tumors for the presence of the activating mutations. We also reviewed the clinical
charts of the patients from whom the tumors were removed. Of 25 tumors, 10 (40%)
contained activating mutations. Patients in the mutation-positive group came to surgery with …
Activating mutations in the gene for the α-chain of G8, the stimulatory regulator of adenylyl cyclase, have been identified in human GH-secreting pituitary tumors. Using the polymerase chain reaction and allele-specific oligonucleotide hybridization, we screened 25 GH-secreting tumors for the presence of the activating mutations. We also reviewed the clinical charts of the patients from whom the tumors were removed. Of 25 tumors, 10 (40%) contained activating mutations. Patients in the mutation-positive group came to surgery with smaller tumors and had lower GH levels. The activating mutations identify a subgroup of GH-secreting pituitary tumors that probably arise from a shared oncogenic mechanism.
Oxford University Press